Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Illumina Shares Fall Sharply on Lower Revenue Guidance

Illumina Inc. shares are trading down more than 15% today as the company reported lower preliminary Q2/19 revenues and updated its annual revenue guidance. In an announcement released this morning, Illumina Inc. (ILMN:NASDAQ) reported lower preliminary reve...
Streetwise Reports | July 16, 2019 |

Nordic American Benefiting from Exceptionally Strong Tanker Market

Shares of Nordic American Tankers are trading 16.5% higher today setting a 52-week intraday high stock price as the company reported great demand for its Suezmax oil tankers. Hamilton, Bermuda-headquartered international tanker company Nordic American Tankers Ltd. (N...
Streetwise Reports | October 9, 2019 |

Navidea Shares Jump 60% on Phase 2b Rheumatoid Arthritis Trial Results

Shares of Navidea Biopharmaceuticals traded 60% higher today on extremely high relative volume after the firm released data from its Phase 2b Rheumatoid Arthritis Tc 99m Tilmanocept Planar Imaging study. Developer of precision immunodiagnostic agents and immunotherape...
Streetwise Reports | October 30, 2019 |

Sandstorm Posts Record Q3 Revenue and Gold Equivalent Ounces Sold

Shares of gold royalty firm Sandstorm Gold traded more than 9% higher today after reporting record revenue for Q3/19. Vancouver, Canada-based gold royalty company Sandstorm Gold Ltd. (SSL:TSX; SAND:AMEX), yesterday announced what it called record 2019 results for ...
Streetwise Reports | November 4, 2019 |

Aquestive Therapeutics Shares Up on Pipeline Update and Raised Full-Year 2019 Guidance

Aquestive Therapeutics shares traded 20% higher today after the firm reported Q3/19 earnings and raised its FY/19 guidance. The firm states it expects to complete its NDA for Libervant buccal film near the end of this month. Yesterday afternoon, specialty pharmaceutic...
Streetwise Reports | November 7, 2019 |

Enphase Energy Powers 40% Higher on Q4 Earnings and Bright Outlook

Shares of Enphase Energy traded 40% higher, setting a new 52-week intraday high price, after reporting Q4/19 and FY/19 financial results. After U.S. markets closed for trading yesterday afternoon, global solar energy technology firm Enphase Energy Inc. (ENP...
Streetwise Reports | February 20, 2020 |

NGL Energy Partners Shares Rise 80% as the Firm Confirms 2020 Guidance

Shares of NGL Energy Partners traded higher after the company confirmed its fiscal 2020 EBITDA guidance and provided an update on current operations and capital expenditure reductions. Midstream energy firm NGL Energy Partners LP (NGL:NYSE) today provided ...
Streetwise Reports | March 20, 2020 |

Allogene Therapeutics Shares Climb 30% on Phase 1 Relapsed/Refractory NHL Study Data

Shares of Allogene Therapeutics traded higher and reached a new 52-week high price after the company reported initial results from its Phase 1 relapsed/refractory non-Hodgkin lymphoma trial. Clinical-stage biotechnology company Allogene Therapeutics Inc. (ALLO:NAS...
Streetwise Reports | May 15, 2020 |

Mersana Therapeutics Trades 60% Higher on Positive Phase 1 Ovarian Cancer Trial Data

Shares of Mersana Therapeutics reached a new 52-week high price after the company reported positive interim data from the expanded portion of its Phase 1 study of XMT-1536 for treatment of ovarian cancer. Clinical-stage biopharmaceutical company Mersana Therapeuti...
Streetwise Reports | May 28, 2020 |

PDC Energy's $1.7 Billion Acquisition of SRC Energy Sends Both Shares Higher

This morning PDC Energy announced that it will acquire SRC Energy in an all-stock deal valued at $1.7 billion. Shares of both companies are trading higher today on the merger news. Early this morning before the market open PDC Energy Inc. (PDCE:NASDAQ) and SRC Ener...
Streetwise Reports | August 27, 2019 |
1 2 3 4 5 6 7 8 9 10 ...